Both in Pharmaceuticals
Precigen vs NewAmsterdam Pharma Company N.V
Over the past year PGEN returned +121.8% and NAMS returned −13.5%; their daily moves had a correlation of 0.28.
PGEN +121.8% NAMS −13.5%Growth of $1, one year, split-adjusted
| Metric | PGEN | NAMS |
|---|---|---|
| Price | $8.05 | $23.81 |
| Market cap | $2.88B | $2.85B |
| Today | +3.07% | +0.98% |
| 1 month | +15.8% | −8.1% |
| 6 months | +147.7% | −18.8% |
| Year to date | +92.6% | −32.1% |
| 1 year | +129.3% | −16.5% |
| Revenue growth (YoY) | +6322.7% | −80.7% |
| Gross margin | 94.9% | 100.0% |
| Net margin | 36.5% | −1732.9% |
| P/E (TTM) | — | — |
| Price / sales | 33.6× | 399.7× |
| Net cash | -$55.7M | $633.9M |
| Dividend yield | — | — |
| Volatility (60d) | 54.5% | 53.2% |
| Short % of float | 23.8% | 23.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).